Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Prospective Longitudinal Salivary and Plasma Cytokine Profiling in Chronic Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Local targets link to admitted publications; unresolved targets remain external evidence.
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells
10.1038/ni1496 · 2007 · External reference
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation – A Report from CIBMTR
10.1016/j.bbmt.2014.10.021 · 2015 · External reference
Cytokine dysregulation in chronic graft versus host disease
10.3109/10428199509051718 · 1995 · External reference
Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease
10.1007/s10875-012-9738-4 · 2012 · External reference
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
10.1038/nature04753 · 2006 · External reference
Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation
10.1182/blood.v98.5.1594 · 2001 · External reference
The Biology of Chronic Graft-versus-Host Disease
10.1016/j.bbmt.2016.09.023 · 2017 · External reference
Allogeneic hematopoietic cell transplantation; the current renaissance
10.1016/j.blre.2018.11.001 · 2019 · External reference
Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation
10.1046/j.1365-2141.2003.04510.x · 2003 · External reference
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation
10.1097/tp.0b013e3181bc267e · 2009 · External reference
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
10.1182/bloodadvances.2021004941 · 2021 · External reference
Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease
2016 · External reference
PROTEOMIC ANALYSIS OF SALIVA FROM PATIENTS WITH ORAL CHRONIC GRAFT-VERSUS-HOST DISEASE
10.1016/j.bbmt.2014.03.031 · 2014 · External reference
Genetic polymorphisms predicting the outcome of bone marrow transplants
10.1111/j.1365-2141.2004.05216.x · 2004 · External reference
IL-8 Levels Early after Bone Marrow Transplant are Associated with Later Complications of Stem Cell Transplantation
10.1016/j.bbmt.2017.12.516 · 2018 · External reference
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
10.1038/s41409-019-0516-2 · 2019 · External reference
Oral Symptom Intensity, Health-Related Quality of Life, and Correlative Salivary Cytokines in Adult Survivors of Hematopoietic Stem Cell Transplantation with Oral Chronic Graft-Versus-Host Disease
10.1016/j.bbmt.2010.01.017 · 2010 · External reference
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
10.1182/blood-2015-10-678706 · 2016 · External reference
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children’s Oncology Group
10.1182/blood-2007-08-106286 · 2008 · External reference
Monocyte and macrophage heterogeneity
10.1038/nri1733 · 2005 · External reference
Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease
2016 · External reference
Updates in chronic graft-versus-host disease
10.1182/hematology.2021000301 · 2021 · External reference
Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
10.1038/ni1254 · 2005 · External reference
Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD
10.1038/bmt.2012.100 · 2013 · External reference
Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)
10.1016/j.jtos.2019.12.005 · 2020 · External reference
Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease
10.1038/s41598-017-15915-3 · 2017 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report
10.1016/j.bbmt.2014.12.001 · 2015 · External reference
The inflammatory profile of cerebrospinal fluid, plasma, and saliva from patients with severe neuropathic pain and healthy controls-a pilot study
10.1186/s12868-021-00608-5 · 2021 · External reference
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
10.1016/s1470-2045(14)71017-4 · 2014 · External reference
Unresolved reference
2023 · External reference
Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population
10.1016/j.cyto.2005.09.002 · 2005 · External reference
Chronic graft-versus-host disease
10.1053/bbmt.2003.50026 · 2003 · External reference
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study
10.1182/blood-2012-01-403063 · 2012 · External reference
Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation
10.1016/j.leukres.2010.03.017 · 2010 · External reference
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
10.1182/blood-2008-03-147322 · 2008 · External reference
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
10.1182/bloodadvances.2017011502 · 2018 · External reference
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation
10.1097/01.tp.0000111769.45088.a2 · 2004 · External reference
Methods for Collecting Saliva
10.1111/j.1749-6632.1993.tb18343.x · 1993 · External reference
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet’s Disease
10.3389/fimmu.2021.724900 · 2021 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report
10.1016/j.bbmt.2015.01.003 · 2015 · External reference
A biomarker panel for acute graft-versus-host disease
10.1182/blood-2008-07-167098 · 2009 · External reference
Gene expression profile of chronic oral graft-versus-host disease
10.1371/journal.pone.0267325 · 2022 · External reference
IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD
10.1038/bmt.2012.210 · 2013 · External reference
Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children’s Oncology Group Study ASCT0031
10.1016/j.bbmt.2011.05.011 · 2011 · External reference
The pro- and anti-inflammatory properties of the cytokine interleukin-6
10.1016/j.bbamcr.2011.01.034 · 2011 · External reference
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation
10.1038/sj.leu.2402946 · 2003 · External reference
Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition
10.3109/00016356408993968 · 1964 · External reference
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study
10.1038/bmt.2009.80 · 2009 · External reference
Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation
10.1097/01.tp.0000092496.05951.d5 · 2003 · External reference
[Detection of Th17/treg cell-associated cytokines in peripheral blood of patients with graft-versus-host disease and its clinical significance]
2011 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
10.1016/j.jtct.2021.02.035 · 2021 · External reference
Development, cytokine profile and function of human interleukin 17-producing helper T cells
10.1038/ni1497 · 2007 · External reference
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantation
10.1111/bjh.18905 · 2023 · External reference
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
10.1038/nm.2807 · 2012 · External reference
Analysis of serum and salivary cytokines among patients with oral cGVHD after Allo-HSCT
10.1111/odi.13658 · 2021 · External reference
